Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Rhea-AI Summary
Azenta (Nasdaq: AZTA) announced its participation in the upcoming 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The company's management team will attend the virtual event scheduled for Tuesday, August 12, 2025. This conference provides an opportunity for investors and analysts to engage with Azenta's leadership through one-on-one meetings.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AZTA declined 2.15%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-10th-annual-needham-virtual-medtech--diagnostics-1x1-conference-302517735.html
SOURCE Azenta
